References
- Ekker MS, Boot EM, Singhal AB, Tan KS, Debette S, Tuladhar AM, de Leeuw FE. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol. 2018; 17(9):790–801.
- Wang X, Lo EH. Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol Neurobiol. 2003; 28:229–44.
- Zan L, Zhang X, Xi Y, Wu H, Song Y, Teng G, et al. Src regulates angiogenic factors and vascular permeability after focal cerebral ischemia–reperfusion. Neuroscience. 2014; 262:118–28.
- Sussman ES, Connolly ES Jr. Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke. Front Neurol. 2013; 4:69. doi: 10.3389/fneur.2013.00069
- Hou Y, Carrim N, Wang Y, Gallant RC, Marshall A, Ni H. Platelets in hemostasis and thrombosis: novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin-mediated protein wave of hemostasis. J Biomed Res. 2015; 29:437–44.
- Oylumlu M, Yıldız A, Oylumlu M, Yüksel M, Polat N, Bilik MZ, et al. Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome. Anatol J Cardiol. 2015; 15:277–83.
- Ozgonul C, Sertoglu E, Ayyildiz O, Mumcuoglu T, Kucukevcilioglu M, Gokce G, Durukan AH. Novel biomarkers for patients with idiopathic acute anterior uveitis: neutrophil to lymphocyte ratio and platelet to lymphocyte ratio. Int J Ophthalmol. 2017; 10:262–6.
- Altintas O, Altintas MO, Tasal A, Kucukdagli OT, Asil T. The relationship of platelet-to-lymphocyte ratio with clinical outcome and final infarct core in acute ischemic stroke patients who have undergone endovascular therapy. Neurol Res. 2016; 38:759–65.
- Neurologybranch of Chinese Medical Association, cerebrovascular disease group of Neurology branch of Chinese Medical Association. Guidelines for diagnosis and treatment of acute ischemic stroke in China, 2018. Chin J Neurol. 2018; 51:666–82.
- Álvarez-Sabín J, Maisterra O, Santamarina E, Kase CS. Factors influencing haemorrhagic transformation in ischaemic stroke. Lancet Neurol. 2013; 12:689–705.
- Smajlović D. Strokes in young adults: epidemiology and prevention. Vasc Health Risk Manag. 2015; 11:157–64.
- Ojha R, Huang D, An H, Liu R, Du C, Shen N, et al. Distribution of ischemic infarction and stenosis of intra-and extracranial arteries in young Chinese patients with ischemic stroke. BMC Cardiovasc Disord. 2015; 15:158. doi: 10.1186/s12872-015-0147-5
- Aigner A, Grittner U, Rolfs A, Norrving B, Siegerink B, Busch MA. Contribution of established stroke risk factors to the burden of stroke in young adults. Stroke. 2017; 48:1744–51.
- Mitchell AB, Cole JW, McArdle PF, Cheng Y-C, Ryan KA, Sparks MJ, et al. Obesity increases risk of ischemic stroke in young adults. Stroke. 2015; 46:1690–2.
- von Sarnowski B, Putaala J, Grittner U, Gaertner B, Schminke U, Curtze S, et al. Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry Patients Study. Stroke. 2013; 44:119–25.
- Modjeski KL, Morrell CN. Small cells, big effects: the role of platelets in transplant vasculopathy. J Thromb Thrombolys. 2014; 37:17–23.
- Xu XR, Zhang D, Oswald BE, Carrim N, Wang X, Hou Y, et al. Platelets are versatile cells: new discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Crit Rev Clin Lab Sci. 2016; 53:409–30.
- Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med. 2019; 39:345–57.
- Balta S, Ozturk C. The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2015; 26:680–1.
- Yüksel M, Yıldız A, Oylumlu M, Akyüz A, Aydın M, Kaya H, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol. 2016; 15:640–7.
- Neuberger U, Möhlenbruch MA, Herweh C, Ulfert C, Bendszus M, Pfaff J. Classification of bleeding events: comparison of ECASS III (European Cooperative Acute Stroke Study) and the new Heidelberg bleeding classification. Stroke. 2017; 48:1983–5.
- Yaghi S, Willey JZ, Cucchiara B, Goldstein JN, Gonzales NR, Khatri P, et al. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017; 48:e343–61.
- Nagaraja N, Tasneem N, Shaban A, Dandapat S, Ahmed U, Policeni B, et al. Cerebral microbleeds are an independent predictor of hemorrhagic transformation following intravenous alteplase administration in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2018; 27:1403–11.
- Wang W, Li M, Chen Q, Wang J. Hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke: mechanisms, models, and biomarkers. Mol Neurobiol. 2015; 52:1572–9.
- Sifat AE, Vaidya B, Abbruscato TJ. Blood-brain barrier protection as a therapeutic strategy for acute ischemic stroke. AAPS J. 2017; 19:957–72.
- Kerenyi L, Kardos L, Szász J, Szatmári S, Bereczki D, Hegedüs K, Csiba L. Factors influencing hemorrhagic transformation in ischemic stroke: a clinicopathological comparison. Eur J Neurol. 2006; 13:1251–5.
- Kablau M, Kreisel SH, Sauer T, Binder J, Szabo K, Hennerici MG, Kern R. Predictors and early outcome of hemorrhagic transformation after acute ischemic stroke. Cerebrovasc Dis. 2011; 32:334–41.